VRTX•benzinga•
Canaccord Genuity Upgrades Vertex Pharmaceuticals to Hold, Raises Price Target to $424
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 12, 2025 by benzinga